OTC Markets OTCPK - Delayed Quote • USD (HOPHD) Follow Compare 1.2400 0.0000 (0.00%) At close: January 10 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000 Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised £340,000 through the issue of 100,000 new ordinary shares ("Placing Shares") at a price of 340p per share (the "Placing"). One institutional investor has subscribed ... Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the opening of the first clinical site for its lead asset, HG-CT-1, targeting relapsed/refractory (R/R) acute myeloid leukemia (AML) in adults. ... Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing LONDON, UNITED KINGDOM / ACCESSWIRE / December 19, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical company developing innovative therapies for blood malignancies, and Kure.ai ("Kure"), a leader in ultrafast CAR-T manufacturing ... Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is FTSE 100 Return HOPHD FTSE 100 YTD 0.00% +1.57% 1-Year -92.25% +7.35% 3-Year -89.42% +10.20%